Multi-omics integration reveals a six-malignant cell maker gene signature for predicting prognosis in high-risk neuroblastoma.

Frontiers in neuroinformatics(2022)

引用 1|浏览5
暂无评分
摘要
This study established a novel six-malignant cell maker gene prognostic model that can be used to predict the prognosis of HRNB patients, which may provide new insight for the treatment and personalized monitoring of HRNB patients.
更多
查看译文
关键词
high-risk neuroblastoma,malignant cell maker gene,multi-omics integration,prognostic model,single-cell
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要